MiNK Therapeutics, Inc. (INKT)

NASDAQ: INKT · Real-Time Price · USD

10.31

+0.03 (0.29%)

Mar 9, 2026, 3:29 PM EDT - Market open

MiNK Therapeutics Employees

MiNK Therapeutics had 23 employees as of December 31, 2024. The number of employees decreased by 8 or -25.81% compared to the previous year.

Employees

23

Change (1Y)

-8

Growth (1Y)

-25.81%

Revenue / Employee

n/a

Profits / Employee

-$537,185

Market Cap

48.40M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	23	-8	-25.81%
Dec 31, 2023	31	-6	-16.22%
Dec 31, 2022	37	4	12.12%
Dec 31, 2021	33	-	-

Related Stocks

Company Name	Employees
MindWalk Holdings	102
Acrivon Therapeutics	78
Kezar Life Sciences	55
LeonaBio	26
Plus Therapeutics	21
Lipocine	16
Nutriband	13
Alterity Therapeutics	9

Employee Rankings

INKT News

4 weeks ago - MiNK Therapeutics Presents New Data of allo-iNKT Cell Therapy as a Potential Disease-Modifying Approach in Idiopathic Pulmonary Fibrosis at Keystone Symposia - GlobeNewsWire
2 months ago - MiNK Therapeutics and University of Wisconsin–Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease - GlobeNewsWire
3 months ago - MiNK Therapeutics Announces New Data Showing MiNK-215 Drives Potent Anti-Tumor Activity in Treatment-resistant Solid Tumors - GlobeNewsWire
4 months ago - MiNK Therapeutics, Inc. (INKT) Q3 2025 Earnings Call Transcript - Seeking Alpha
4 months ago - MiNK Therapeutics Reports Durable Responses and Immune Reactivation with Allo-iNKT Cell Therapy agenT-797 in PD-1–Refractory Solid Tumors at SITC 2025 - GlobeNewsWire
5 months ago - MiNK Therapeutics Appoints Colonel (Ret.) John B. Holcomb, MD, to Board of Directors - GlobeNewsWire
5 months ago - MiNK Therapeutics Dr. Jennifer Buell to Deliver Featured Plenary at 10th Annual CAR-TCR Summit in Boston, MA - GlobeNewsWire
6 months ago - MiNK Therapeutics Appoints Dr. Terese C. Hammond to Accelerate iNKT Pipeline to Pivotal Development - GlobeNewsWire